Videos / Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Sushil Pant
Frozen Shoulder – A Practical Guide to Assessment and Management
Dr Robert Hungerford
Implementing the Four Pillars of Heart Failure Management in GP
Prof Robert Norman
PCOS Update
Dr Clare Tiedeman
Biologics in COPD – 20% of Your Patients Could Benefit
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
